IDO1 and neoplasm: However, mounting evidence suggests that despite their activating phenotype, TIL exhibit functional impairment due to the absence of Th1 cytokines (such as IL-2, IFN-γ, and IL-12) and the prevalence of Treg cells cytokines (such as IDO or TGF-β) at tumor sites.